Sfoglia per Autore
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
2023 Massimino, L; Palmieri, O; Facoetti, A; Fuggetta, D; Spanò, S; Lamparelli, L; D'Alessio, S; Cagliani, S; Furfaro, F; D'Amico, F; Zilli, A; Fiorino, G; Parigi, T; Noviello, D; Latiano, A; Bossa, F; Latiano, T; Pirola, A; Mologni, L; Piazza, R; Abbati, D; Perri, F; Bonini, C; Peyrin-Biroulet, L; Malesci, A; Jairath, V; Danese, S; Ungaro, F
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia
2020 Fontana, D; Ramazzotti, D; Aroldi, A; Redaelli, S; Magistroni, V; Pirola, A; Niro, A; Massimino, L; Mastini, C; Brambilla, V; Bombelli, S; Bungaro, S; Morotti, A; Rea, D; Stagno, F; Martino, B; Campiotti, L; Caocci, G; Usala, E; Merli, M; Onida, F; Bregni, M; Elli, E; Fumagalli, M; Ciceri, F; Perego, R; Pagni, F; Mologni, L; Piazza, R; Gambacorti-Passerini, C
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
2020 Colombo, F; Pintarelli, G; Galvan, A; Noci, S; Corli, O; Skorpen, F; Klepstad, P; Kaasa, S; Pigni, A; Brunelli, C; Roberto, A; Piazza, R; Pirola, A; Gambacorti Passerini, C; Caraceni, A
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Magistroni, V; Mauri, M; D'Aliberti, D; Mezzatesta, C; Crespiatico, I; Nava, M; Fontana, D; Sharma, N; Parker, W; Schreiber, A; Yeung, D; Pirola, A; Redaelli, S; Massimino, L; Wang, P; Khandelwal, P; Citterio, S; Viltadi, M; Bombelli, S; Rigolio, R; Perego, R; Boultwood, J; Morotti, A; Saglio, G; Dong-Wook, K; Branford, S; Gambacorti Passerini, C; Piazza, R
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub
2018 Piazza, R; Magistroni, V; Redaelli, S; Mauri, M; Massimino, L; Sessa, A; Peronaci, M; Lalowski, M; Soliymani, R; Mezzatesta, C; Pirola, A; Banfi, F; Rubio, A; Rea, D; Stagno, F; Usala, E; Martino, B; Campiotti, L; Merli, M; Passamonti, F; Onida, F; Morotti, A; Pavesi, F; Bregni, M; Broccoli, V; Baumann, M; Gambacorti-Passerini, C
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells
2018 Mologni, L; Costanza, M; Sharma, G; Viltadi, M; Massimino, L; Citterio, S; Purgante, S; Raman, H; Pirola, A; Zucchetti, M; Piazza, R; Gambacorti-Passerini, C
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes
2017 Piazza, R; Ramazzotti, D; Spinelli, R; Pirola, A; De Sano, L; Ferrari, P; Magistroni, V; Cordani, N; Sharma, N; Gambacorti-Passerini, C
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes
2017 Piazza, R; Ramazzotti, D; Spinelli, R; Pirola, A; De Sano, L; Ferrari, P; Magistroni, V; Cordani, N; Sharma, N; GAMBACORTI PASSERINI, C
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis
2016 Piazza, R; Mologni, L; Ramazzotti, D; Spinelli, R; Pirola, A; De Sano, L; Ferrari, P; Magistroni, V; Sharma, N; Khandelwal, P; Gambacorti-Passerini, C
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma
2016 Redaelli, S; Ceccon, M; Antolini, L; Rigolio, R; Pirola, A; Peronaci, M; GAMBACORTI PASSERINI, C; Mologni, L
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma
2016 Pintarelli, G; Dassano, A; Cotroneo, C; Galvan, A; Noci, S; Piazza, R; Pirola, A; Spinelli, R; Incarbone, M; Palleschi, A; Rosso, L; Santambrogio, L; Dragani, T; Colombo, F
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma
2015 Redaelli, S; Ceccon, M; Pirola, A; Peronaci, M; Gambacorti-Passerini, C; Mologni, L
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors
2015 Mologni, L; Ceccon, M; Fontana, D; Pirola, A; Piazza, R; Gambacorti-Passerini, C
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783))
2015 Ceccon, M; Mologni, L; Giudici, G; Piazza, R; Pirola, A; Fontana, D
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
2015 GAMBACORTI PASSERINI, C; Donadoni, C; Parmiani, A; Pirola, A; Redaelli, S; Signore, G; Piazza, V; Malcovati, L; Fontana, D; Spinelli, R; Magistroni, V; Gaipa, G; Peronaci, M; Morotti, A; Panuzzo, C; Saglio, G; Usala, E; Kim, D; Rea, D; Zervakis, K; Viniou, N; Symeonidis, A; Becker, H; Boultwood, J; Campiotti, L; Carrabba, M; Elli, E; Bignell, G; Papaemmanuil, E; Campbell, P; Cazzola, M; Piazza, R
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
2015 Mori, S; Vagge, E; Le Coutre, P; Abruzzese, E; Martino, B; Pungolino, E; Elena, C; Pierri, I; Assouline, S; D'Emilio, A; Gozzini, A; Giraldo, P; Stagno, F; Iurlo, A; Luciani, M; De Riso, G; Redaelli, S; Kim, D; Pirola, A; Mezzatesta, C; Petroccione, A; Lodolo D'Oria, A; Crivori, P; Piazza, R; GAMBACORTI PASSERINI, C
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia
2015 Niro, A; Piazza, R; Merati, G; Pirola, A; Donadoni, C; Fontana, D; Redaelli, S; Mezzatesta, C; Renso, R; Farina, F; Rea, D; Gambacorti-Passerini, C
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia
2015 Niro, A; Piazza, R; Merati, G; Pirola, A; Donadoni, C; Fontana, D; Redaelli, S; Mezzatesta, C; Renso, R; Cecchetti, C; Rea, D; Gambacorti-Passerini, C
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma
2015 Ceccon, M; Mologni, L; Giudici, G; Piazza, R; Pirola, A; Fontana, D; GAMBACORTI PASSERINI, C
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922
2015 Mologni, L; Ceccon, M; Pirola, A; Chiriano, G; Piazza, R; Scapozza, L; GAMBACORTI PASSERINI, C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile